NO20030531L - Tartratsalter av tiazolidindionderivater - Google Patents

Tartratsalter av tiazolidindionderivater

Info

Publication number
NO20030531L
NO20030531L NO20030531A NO20030531A NO20030531L NO 20030531 L NO20030531 L NO 20030531L NO 20030531 A NO20030531 A NO 20030531A NO 20030531 A NO20030531 A NO 20030531A NO 20030531 L NO20030531 L NO 20030531L
Authority
NO
Norway
Prior art keywords
tartrate salts
thiazolidinedione derivatives
tartrate
diabetes mellitus
thiazolidinedione
Prior art date
Application number
NO20030531A
Other languages
English (en)
Other versions
NO324598B1 (no
NO20030531D0 (no
Inventor
Bernadette Marie Choudary
Andrew Simon Craig
Tim Chien Ting Ho
Deirde O'keeffe
Donald Colin Mackenzie
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20030531D0 publication Critical patent/NO20030531D0/no
Publication of NO20030531L publication Critical patent/NO20030531L/no
Publication of NO324598B1 publication Critical patent/NO324598B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

En farmasøytisk forbindelse 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]benzyl]-tiazolidin-2,4-dion L(+) tartrat eller et solvat derav kan anvendes for terapi og/eller profylakse av diabetes mellitus, tilstander assosiert med diabets mellitus og visse komplikasjoner derav.Det beskrives farmasøytiske preparater inneholdende forbindelsene samt preparatenes anvendelse.
NO20030531A 2000-08-04 2003-02-03 Tartratsalter av tiazolidindionderivat, fremgangsmate for fremstilling drav, anvendelse derav samt farmasoytisk preparat inneholdende saltet NO324598B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019223.7A GB0019223D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003506 WO2002012231A1 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative

Publications (3)

Publication Number Publication Date
NO20030531D0 NO20030531D0 (no) 2003-02-03
NO20030531L true NO20030531L (no) 2003-02-03
NO324598B1 NO324598B1 (no) 2007-11-26

Family

ID=9897025

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030531A NO324598B1 (no) 2000-08-04 2003-02-03 Tartratsalter av tiazolidindionderivat, fremgangsmate for fremstilling drav, anvendelse derav samt farmasoytisk preparat inneholdende saltet

Country Status (35)

Country Link
US (1) US20040087629A1 (no)
EP (1) EP1305310B1 (no)
JP (1) JP2004505969A (no)
KR (1) KR100754701B1 (no)
CN (2) CN101712678A (no)
AP (1) AP1813A (no)
AT (1) ATE386739T1 (no)
AU (1) AU2001276502A1 (no)
BG (1) BG107603A (no)
BR (1) BR0112983A (no)
CA (1) CA2417818A1 (no)
CY (1) CY1107421T1 (no)
CZ (1) CZ301281B6 (no)
DE (1) DE60132897T2 (no)
DK (1) DK1305310T3 (no)
DZ (1) DZ3417A1 (no)
EA (1) EA005295B1 (no)
EC (1) ECSP034466A (no)
ES (1) ES2299498T3 (no)
GB (1) GB0019223D0 (no)
HK (1) HK1057360A1 (no)
HR (1) HRP20030067A2 (no)
HU (1) HUP0300724A3 (no)
IL (2) IL154274A0 (no)
MA (1) MA25831A1 (no)
MX (1) MXPA03001083A (no)
NO (1) NO324598B1 (no)
NZ (1) NZ524029A (no)
PL (1) PL360693A1 (no)
PT (1) PT1305310E (no)
SK (1) SK287243B6 (no)
UA (1) UA76719C2 (no)
WO (1) WO2002012231A1 (no)
YU (1) YU14503A (no)
ZA (1) ZA200300960B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288095B1 (en) * 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group Plc Substituierte Thiazolidindionderivate
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5874454A (en) * 1993-09-15 1999-02-23 Warner-Lambert Company Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
EP0777469A1 (en) * 1994-02-10 1997-06-11 Smithkline Beecham Plc Use of insulin sensitisers for treating renal diseases

Also Published As

Publication number Publication date
NO324598B1 (no) 2007-11-26
KR100754701B1 (ko) 2007-09-03
DZ3417A1 (fr) 2002-02-14
CN101712678A (zh) 2010-05-26
DE60132897D1 (de) 2008-04-03
YU14503A (sh) 2006-01-16
ZA200300960B (en) 2004-04-19
CZ2003315A3 (cs) 2004-02-18
IL154274A0 (en) 2003-09-17
ECSP034466A (es) 2003-06-25
HUP0300724A3 (en) 2005-04-28
SK1432003A3 (en) 2004-03-02
ATE386739T1 (de) 2008-03-15
CA2417818A1 (en) 2002-02-14
HUP0300724A2 (hu) 2003-11-28
MXPA03001083A (es) 2003-05-27
GB0019223D0 (en) 2000-09-27
PT1305310E (pt) 2008-05-12
BG107603A (bg) 2003-09-30
SK287243B6 (sk) 2010-04-07
NO20030531D0 (no) 2003-02-03
US20040087629A1 (en) 2004-05-06
DE60132897T2 (de) 2009-04-09
HRP20030067A2 (en) 2004-06-30
CN1455777A (zh) 2003-11-12
PL360693A1 (en) 2004-09-20
HK1057360A1 (en) 2004-04-02
UA76719C2 (uk) 2006-09-15
MA25831A1 (fr) 2003-07-01
IL154274A (en) 2009-02-11
ES2299498T3 (es) 2008-06-01
JP2004505969A (ja) 2004-02-26
EA005295B1 (ru) 2004-12-30
AP1813A (en) 2008-01-04
AP2003002735A0 (en) 2003-03-31
KR20030022354A (ko) 2003-03-15
CZ301281B6 (cs) 2009-12-30
AU2001276502A1 (en) 2002-02-18
EP1305310B1 (en) 2008-02-20
NZ524029A (en) 2004-07-30
EP1305310A1 (en) 2003-05-02
WO2002012231A1 (en) 2002-02-14
CY1107421T1 (el) 2012-12-19
EA200300232A1 (ru) 2003-06-26
BR0112983A (pt) 2003-06-10
DK1305310T3 (da) 2008-06-16

Similar Documents

Publication Publication Date Title
AP1545A (en) Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
NO20030531L (no) Tartratsalter av tiazolidindionderivater
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
DK1349855T3 (da) 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsalt
AP1600A (en) Combination of a thiazolidinedione and a sulphonylurea for treating diabetes
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
DK1446404T3 (da) Rosiglitazonedisylater og deres anvendelse som antidiabetika
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
NO20076517L (no) Natriumsalter av 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoksyl]benzyl]tiazolidin-2,4-dion
NO20075507L (no) Tiazolidindionderivater og deres anvendelse som antidiabetiske midler
MXPA02012100A (es) Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.
AP2003002737A0 (en) Tartrate salts of thiazolidinedione derivatives
DK1315721T3 (da) Et Thiazolidindionderivat og dets anvendelse som et antidiabetisk middel
YU93002A (sh) 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil)tiazolidin-2,4-dion hidrojodid kao farmaceutski preparat
WO2002028857A8 (en) Polymorphs of pioglitazone hydrochloride and their use as antidiabetics
WO2003099337A3 (en) Inclusion complexes of rosiglitazone
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees